Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000315066-25-002911·CytomX Therapeutics, Inc.
Schedule 13G ownership disclosure
CytomX Therapeutics Inc
COMMON STOCK · CUSIP: 23284F105
Event date: 2025-10-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 20,519,967.00 · Class: 12.4%
- Abigail P. Johnson
Shares: 20,519,967.00 · Class: 12.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-002911
- Form type
- SCHEDULE 13G/A
- Filer
- CytomX Therapeutics, Inc.
- CIK
- CIK 1501989
- Filed
- Nov 07, 2025
- Reporting period
- Oct 31, 2025
- Description
- Schedule 13G beneficial ownership